Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600171 · ClinicalTrials.gov registry record · Phase 2
Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 614
- Enrollment target
NCT00600171 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 614 participants.
The verdict
NCT00600171, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 614 participants
- Enrollment target
Study Summary
This study is designed to determine if the investigational drug is effective and safe in individuals with asthma
Interventions
- DRUG Placebo
- DRUG GW642444M
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 614 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00600171
The ClinicalTrials.gov registry entry for NCT00600171 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 614 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00600171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00600171 about?
NCT00600171 is a clinical study titled "Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.". This study is designed to determine if the investigational drug is effective and safe in individuals with asthma
What is the current status of trial NCT00600171?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 614 participants. The study started on 2007-12. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00600171?
The interventions under investigation include: Placebo (DRUG), GW642444M (DRUG).
Who is sponsoring clinical trial NCT00600171?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.